跳至主要内容
临床试验/ISRCTN43104115
ISRCTN43104115已完成未知

Acupuncture for Sequelae of Bell's Palsy: a randomised wait-list controlled pilot trial

Kyung Hee University (South Korea)0 个研究点目标入组 20 人开始时间: 2010年7月6日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
20

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

性别
All

入选标准

  • 1. Aged between 18-65
  • 2. Diagnosis of Bell's palsy (ICD-10 G51.0), at least 6 months prior to recruitment
  • 3. FDI (Facial Disability Index) score of below 70 in Physical Function, and below 80 in Social/Well-being Function
  • 4. Provided written informed consent

排除标准

  • 1. Secondary facial palsy resulting from specific disease such as infection, multiple neuritis, tumour invading the temporal region, cerebral contusion or stroke
  • 2. Patient manifesting Ramsay-Hunt syndrome
  • 3. Bilateral facial palsy
  • 4. Recurred facial palsy
  • 5. Received orally administered corticosteroids or anti-viral agent(aciclovir, valaciclovir, famciclovir, ganciclovir) within 1 month before enrolment
  • 6. Received alternative and complementary modality, i.e. acupuncture, moxibustion, vesicant therapy or massage for treating Bell's palsy within 3 months
  • 7. Received operation, i.e. facial nerve decompression, facial nerve and muscle reconstruction for treating Bell's palsy
  • 8. Suffering serious medical condition such as uncontrolled hypertension, diabetes mellitus requiring insulin injection, past or current malignant tumour, severe dyslipidemia or liver and kidney dysfunction, anaemia, active pulmonary tuberculosis, other infectious disease or systemic diseases insufficient for acupuncture treatment
  • 9. Other neurologic illness
  • 10. Participating in another clinical trial
  • 11. Suffering psychiatric illness insufficient for participation in clinical trial
  • 12. Unable to obtain written consent
  • 13. Pregnant or nursing status, or planning conception during treatment
  • 14. Scar in administration area or systemic illness unsuitable for acupuncture treatment in the judgement of the investigator

研究者

发起方
Kyung Hee University (South Korea)

相似试验